Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão



Título del documento: Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão
Revista: Revista de saude publica
Base de datos:
Número de sistema: 000536019
ISSN: 0034-8910
Autores: 1
2
4
6
7
8
5
10
4
11
1
9
13
2
14
1
10
14
1
1
1
Instituciones: 1Universidade Federal do Maranhão, Departamento de Saúde Pública, São Luís. Brasil
2Laboratório Central do Maranhão, São Luís, MA. Brasil
3Universidade CEUMA, São Luís, MA. Brasil
4Universidade Federal do Maranhão, Departamento de Medicina I, São Luís. Brasil
5Saúde do Estado do Maranhão, Hospital Presidente Vargas, São Luís, MA. Brasil
6Saúde do Estado do Maranhão, São Luís, MA. Brasil
7Universidade Federal do Maranhão, Departamento de Ciências Fisiológicas, São Luís. Brasil
8Universidade Federal do Maranhão, Departamento de Engenharia Elétrica, São Luís. Brasil
9Universidade Federal do Maranhão, Hospital Universitário, São Luís. Brasil
10Universidade Federal do Maranhão, Departamento de Engenharia da Computação, São Luís. Brasil
11Universidade Federal do Maranhão, Curso de Medicina, Pinheiro. Brasil
12Secretaria Municipal de Saúde, São Luís, MA. Brasil
13Saúde do Estado do Maranhão, Centro de Informações Estratégicas de Vigilância em Saúde, São Luís, MA. Brasil
14Universidade Federal do Maranhão, Programa de Pós-Graduação em Saúde Coletiva, São Luís. Brasil
Año:
Volumen: 54
País: Brasil
Idioma: Inglés
Resumen en inglés OBJECTIVE: To estimate the seroprevalence of SARS-CoV-2 in the state of Maranhão, Brazil. METHODS: A population-based household survey was performed, from July 27, 2020 to August 8, 2020. The estimates considered clustering, stratification and non-response. Qualitative detection of IgM and IgG antibodies was performed in a fully-automated Elecsys® Anti-SARS-CoV-2 electrochemiluminescence immunoassay on the Cobas® e601 analyzer (Roche Diagnostics). RESULTS: In total, 3,156 individuals were interviewed. Seroprevalence of total antibodies against SARS-CoV-2 was 40.4% (95%CI 35.6-45.3). Population adherence to non-pharmaceutical interventions was higher at the beginning of the pandemic than in the last month. SARS-CoV-2 infection rates were significantly lower among mask wearers and among those who maintained social and physical distancing in the last month compared to their counterparts. Among the infected, 26.0% were asymptomatic. The infection fatality rate (IFR) was 0.14%, higher for men and older adults. The IFR based on excess deaths was 0.28%. The ratio of estimated infections to reported cases was 22.2. CONCLUSIONS: To the best of our knowledge, the seroprevalence of SARS-CoV-2 estimated in this population-based survey is one of the highest reported. The local herd immunity threshold may have been reached or might be reached soon.
Keyword: Seroepidemiologic Studies,
Coronavirus Infections,
Immunity, Herd,
Mortality
Texto completo: Texto completo (Ver HTML) Texto completo (Ver PDF)